A Large-scale genetic association study of esophageal adenocarcinoma risk.
The incidence of esophageal adenocarcinoma (EA) has been increasing rapidly, particularly among white males, over the past few decades in the USA. However, the etiology of EA and the striking male predominance is not fully explained by known risk factors. To identify susceptible genes for EA risk, we conducted a pathway-based candidate gene association study on 335 Caucasian EA cases and 319 Caucasian controls. A total of 1330 single-nucleotide polymorphisms (SNPs) selected from 354 genes were analyzed using an Illumina GoldenGate assay. The genotyped common SNPs include missense and exonic SNPs, SNPs within untranslated regions and 2 kb 5' of the gene, and tagSNPs for genes with little functional information available. Logistic regression adjusted for potential confounders was used to assess the genetic effect of each SNP on EA risk. We also tested gene-gender interactions using the likelihood ratio tests. We found that the genetic variants in the apoptosis pathway were significantly associated with EA risk after correcting for multiple comparisons. SNPs of rs3127075 in Caspase-7 (CASP7) and rs4661636 in Caspase-9 (CASP9) genes that play a critical role in apoptosis were found to be associated with an increased risk of EA. A protective effect of SNP rs572483 in the progesterone receptor (PGR) gene was observed among women carrying the variant G allele [adjusted odds ratio (OR) = 0.19; 95% confidence interval (CI) = 0.08-0.46] but was not observed among men (adjusted OR = 1.38; 95% CI = 0.95-2.00). In conclusion, this study suggests that the genetic variants of CASP7 and CASP9 in the apoptosis pathway may be important predictive markers for EA susceptibility and that PGR in the sex hormone signaling pathway may be associated with the gender differences in EA risk.
Liu
Chen-Yu
CY
Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA.
Wu
Michael C
MC
Chen
Feng
F
Ter-Minassian
Monica
M
Asomaning
Kofi
K
Zhai
Rihong
R
Wang
Zhaoxi
Z
Su
Li
L
Heist
Rebecca S
RS
Kulke
Matthew H
MH
Lin
Xihong
X
Liu
Geoffrey
G
Christiani
David C
DC
D000230:Adenocarcinoma / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis; D053179:Caspase 7 / Q000235:genetics; D053453:Caspase 9 / Q000235:genetics; D004938:Esophageal Neoplasms / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D005260:Female; D056726:Genetic Association Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
C505520:CASP7 protein, human; C506433:CASP9 protein, human; D053179:Caspase 7; D053453:Caspase 9
Gastroenterology. 1995 Nov;109(5):1541-6
7557137
Cancer. 2006 Oct 1;107(7):1570-7
16933328
Annu Rev Cell Dev Biol. 1999;15:269-90
10611963
Semin Cancer Biol. 2005 Dec;15(6):474-83
16043360
Nat Genet. 2000 May;25(1):25-9
10802651
Ann Surg Oncol. 2009 Jul;16(7):2028-34
19412632
Nature. 1998 Nov 12;396(6707):119-22
9823889
Bioinformatics. 2003 Jan 22;19(2):287-8
12538253
Science. 1995 Mar 10;267(5203):1456-62
7878464
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D322-6
16381878
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
10592173
Gastroenterology. 2007 Aug;133(2):403-11
17681161
J Rheumatol. 2008 Oct;35(10):1912-8
18785314
Cancer Metastasis Rev. 2008 Jun;27(2):273-88
18224295
Am J Gastroenterol. 1997 Nov;92(11):2012-6
9362182
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2598-604
16284384
Environ Health Perspect. 2001 Jan;109(1):A22-3
11171540
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D354-7
16381885
Ann Surg Oncol. 2009 May;16(5):1378-83
19224282
Cancer Causes Control. 1996 May;7(3):322-7
8734825
J Mol Biol. 1987 Apr 5;194(3):391-6
3305960
Am J Hum Genet. 2008 Feb;82(2):386-97
18252219
Bioinformatics. 1998;14(8):656-64
9789091
Semin Radiat Oncol. 2007 Jan;17(1):2-9
17185192
J Natl Cancer Inst. 2005 Jan 19;97(2):142-6
15657344
Blood. 2009 Mar 19;113(12):2742-5
19168786
Trends Genet. 1997 Apr;13(4):163
9097728
J Natl Cancer Inst. 1997 Sep 3;89(17):1277-84
9293918
Blood. 2009 Jul 9;114(2):264-7
19414860
Bioinformatics. 2002 Nov;18(11):1542-3
12424129
Med Clin North Am. 2000 Sep;84(5):1137-61
11026922
BMC Bioinformatics. 2008 Jun 24;9:292
18577223
Oncogene. 2003 Sep 11;22(39):8048-52
12970753
Am J Gastroenterol. 2008 Mar;103(3):788-97
18341497
Nat Genet. 2004 May;36(5):431-2
15118671
Rheumatology (Oxford). 2007 Aug;46(8):1243-7
17504820
Biochem Soc Symp. 2003;(70):233-42
14587296
Cancer Res. 2002 May 15;62(10):2819-23
12019159
Int J Cancer. 2002 Jun 20;99(6):860-8
12115489
J Clin Oncol. 2009 Dec 1;27(34):5823-9
19826114
Surg Oncol Clin N Am. 2002 Apr;11(2):235-56
12424848
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2114-22
19531679
Cancer. 1998 Nov 15;83(10):2049-53
9827707
Nucleic Acids Res. 2007 Jan;35(Database issue):D26-31
17148475
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W635-41
16845089
Nat Cell Biol. 1999 Oct;1(6):E143-5
10559972
Hum Mol Genet. 2006 Jun 15;15(12):1963-71
16687442
Gastroenterol Clin North Am. 2009 Mar;38(1):75-91, viii
19327568
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
742764
Cancer. 2001 Aug 1;92(3):549-55
11505399
Lung Cancer. 2009 Jul;65(1):19-24
19058873
Carcinogenesis. 2009 Jul;30(7):1193-201
19406933
Am J Gastroenterol. 1997 Feb;92(2):212-5
9040193